Lakefront Biotherapeutics NV (G1LP34.SA) Q4 2024 Earnings

Oct 30Confirmed
Q1 2024
Q2 2024
Q3 2024
Q4 2024
-10.58
-2.78
5.03
12.84

Details

Expected EPS
-0.9963741193979
Actual EPS
-4.747693807819999
Surprise EPS
-3.75
Surprise Percent
-376.5%

Description

⁨Lakefront Biotherapeutics NV⁩ (⁦G1LP34.SA⁩) has reported earnings of ⁦-4.747693807819999⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts